Header cover image

Taiwanese Biotech Breakthroughs

Results

1

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

1 companies

Medigen Vaccine Biologics

Market Cap: NT$19.3b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

6547

NT$58.80

7D

6.7%

1Y

21.6%